Intermedia Remazolam Benzenesulfonate (CAS No. 308242-23-1)
Synonyma:(3S)-(7-BroMo-2-oxo-5-pyridin-2-yl-2, 3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionicum acidum Methylester; Methyl3-[(3S)-7-bromo-2-oxo-5-(2-pyridinyl)-2, 3-dihydro-1H-1, 4-benzodiazepin-3-yl] propanoate; (S)-Methyl3-(7-bromo-2-oxo-5-(pyridin-2-yl)-2, 3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanoate; 3-[(S)-7-bromo-2-oxo-5-pyridin-2-yl-2, 3-dihydro-1H-1, 4-benzodiazepin-3-yl]-propionicacidmethylester.
CAS No.:308242-23-1
Formulae hypotheticae:C18H16BrN3O3
Pondus hypotheticum:402.24
Applicatio: Pharmaceuticalia, media, APIs, consuetudo, synthesis, oeconomia
Utitur:Intermedia Remazolam Benzenesulfonate
Structure
Praelatio:Sansoni, Quality, Aliquam Price, Fast Delivery, Velox Responsio
Genera cognata:Fine Chemicals
| fervens | 545.3±50.0 °C (Predicta) |
| Densitas | 1.52±0.1 g/cm3(Predicta) |
| Repono conditione | Signatum in siccis, Locus Temperature |
| pKa | 11.15±0.70 (Praedicta) |
| Speciales determinationes secundum elit elit | |
| Aspectus | Alba ad flavo pulveris |
| Aquae | 1.0% max |
| Isomer | 1.5%max |
| Puritas | 98.0％min |
Cautiones pro tutum pertractatio;
Bene ventilatas tractantem in loco. Apta tutela vestitus. Fuge contactum cum cute et oculis. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Condiciones pro repono, quaslibet incompatibiles:
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.
Jingye habet 86 reactoria in summa, quorum volumen electri reactor est 69, ab 50 ad 3000L. Numerus reactorum immaculatorum est 18, ab 50 ad 3000L. QC centenariis omnium instrumentorum analyticorum instruitur. Ad productionem commercialem et analysim comprehendendam producti occurrere potest. Hoc productum est productum macula superior et tradi potest secundum necessitates Lorem.
Jiangsu Jingye Pharmaceutical Co, Ltd., olim Jintan Depei Chemical Co, Ltd. nominatus est, qui anno 1994 instituit, et ad fabricam pharmaceuticam professionalem anno 2016. Post duo decennia evolutionis Jingye pharmaceutica ad professionalem et comprehensivam pharmaceuticam crevit. inceptum coniungendo R&D, productionem, importationem et exportationem cum duobus subsidiariis in Shanghai et Lianyungang sitis.